PBYI EBITDA Growth
Puma Biotechnology Inc · EBITDA Growth
PBYI EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-28.64%period ending
PBYI TTM EBITDA YoY % (99.90% → -28.64%)
Year-over-year change
High-resolution chart · PNG
PBYI ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -28.6376% | |
| -17.6837% | |
| 10.9535% | |
| 3.0213% | |
| 84.3821% | |
| 34.2512% | |
| 2.7528% | |
| 69.9407% | |
| 59.2928% | |
| 47.3648% | |
| 116.1808% | |
| -7.2635% | |
| 261.9982% | |
| 204.2176% | |
| 508.6669% | |
| 234.3626% | |
| -50.748% | |
| -3,242.7491% | |
| 85.169% | |
| 31.6925% | |
| 57.2626% | |
| 98.6987% | |
| 31.9816% | |
| 52.6368% | |
| 69.5593% | |
| 20.6689% | |
| 44.8725% | |
| 46.353% | |
| 66.1051% | |
| 67.6976% | |
| 66.9868% | |
| 55.6506% | |
| 30.5947% | |
| 14.1496% | |
| -4.7265% | |
| -12.7266% | |
| -11.0494% | |
| -7.312% | |
| -15.0073% | |
| -17.7306% | |
| -29.5923% | |
| -48.0224% | |
| -69.0839% | |
| -104.4156% | |
| -126.3004% | |
| -179.5463% | |
| -160.3345% | |
| -82.2544% | |
| -22.9648% | |
| 15.8128% | |
| 26.6551% | |
| 3.2683% | |
| -94.6599% | |
| -232.0884% | |
| -605.6178% | |
| -16,447.2106% | |
| -78,795.1664% | |
| -146,489.3634% | |
| -65,706.8916% | |
| -2,665.1502% | |
| -240.8215% | |
| 1.9644% | |
| 5.1081% | |
| 13.4597% | |
| 16.2965% | |
| 0.468% | |
| -19.5484% | |
| 99.8956% |